| PWR |
Report |
Operating EPS (Q2 2026) |
BEAT |
pred ~$3.70 vs. cons $3.28 |
HIGH |
| PWR |
Report |
U&I Operating Margin (Q2 2026) |
BEAT |
pred ~8.55% vs. cons 8.23% |
MEDIUM |
| PWR |
Report |
Total Backlog (Q2 2026) |
BEAT |
pred ~$51.0B vs. cons $49.22B |
MEDIUM |
| PWR |
Guide |
FY2026 Operating EPS (FY2026) |
BETTER |
guide ~$14.80-$15.50 (mid $15.15) vs. cons $14.04 |
MEDIUM |
| PWR |
Guide |
FY2026 Revenue (FY2026) |
BETTER |
guide ~$36.0-$36.5B (mid $36.25B) vs. cons $35.02B |
MEDIUM |
| PWR |
Guide |
FY2026 Operating EBITDA (FY2026) |
BETTER |
guide ~$3.80-$3.95B (mid $3.875B) vs. cons $3.597B |
MEDIUM |
| PWR |
Guide |
Qualitative - Backlog/Transmission (H2 2026) |
BETTER |
large transmission bookings entering backlog H2; tech/DC growth outlook raised again vs. no prior formal guide |
HIGH |
| PWR |
Return |
Day-1 residual (stock − beta × S&P 500) |
+1.5% |
— |
MEDIUM |
| PWR |
Return |
5-day cumulative residual |
+2.5% (STABILIZE) |
STABILIZE - estimate revisions follow FY guide raise but sector sell-the-news dynamic and CEO overhang limit follow-through |
MEDIUM |